" class="no-js "lang="en-US"> Elizabeth Mora - Medtech Alert
Sunday, October 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Elizabeth Mora

Elizabeth Mora

About Elizabeth Mora

C Suite senior executive with 30+ years leading large, complex organizations
Director of a publicly traded company
SEC Financial Expert – Audit Committee Chair
Compensation Committee Chair
Transformational M&A expertise
IPO experience
Global Supply Chain strategy and tactics
Adviser to CEOs and management
LGBT leader
Mentor to women and underrepresented minorities
Emotional Intelligence student and teacher
Champion for Diversity and Inclusion

Related Story

Appointments

 binx health Adds Industry Leaders

binx health Adds Industry Leaders, Elizabeth Mora and Naomi Kelman to Board of Directors

September 8 2021

binx health, a healthcare technology and diagnostics company that brings convenient care to the locations […]